What is multiple sclerosis and how its treatment landscape has changed over the years

Focus on the Future: A Look at the Eczema Research and Treatment LandscapeПодробнее

Changes in the MS treatment landscape over the last 2 yearsПодробнее

Understanding MS treatment options, The Future MS Landscape including Biosimilars PLUS Visual issuesПодробнее

The Multiple Sclerosis Treatment Era (A Reflection on 30 years of MS treatments)Подробнее

The Expanding Landscape of Therapeutic Targets in ALS Clinical TrialsПодробнее

Dr. Tom Pitts discusses Multiple Sclerosis Symptoms and Treatment LandscapeПодробнее

BTK Inhibitors for MS: Progress in the Development of an Emerging Therapeutic ApproachПодробнее

NMOSD Multidisciplinary Approach Webinar, 25 June 2021 - Dr. Suzan Ibrahim NooriПодробнее

Drs. Adam Chaifetz & Adrienne DeBerry: The Changing Landscape of MS Treatment: January 2022Подробнее

How Can We Apply Guidelines in the Rapidly Changing MS Treatment Landscape?Подробнее

Risk Mitigation in Multiple Sclerosis TherapiesПодробнее

Multiple Sclerosis Webinar: The Emerging and Evolving Field of NeuroimmunologyПодробнее

Multiple Sclerosis Webinar: Ocrelizumab Q&A with Dr. Tim VollmerПодробнее

John Schafer, MD: New Treatment Options for Multiple SclerosisПодробнее

Challenges & changes in the current treatment landscape for MS - Podcast with Professor Bill CarrollПодробнее

April 21, 2016 - Understanding the Multiple Sclerosis Medication LandscapeПодробнее

What role does Autologous Haematopoietic Stem Cell Transplant (AHSCT) play in MS treatment?Подробнее

Multiple Sclerosis Webinar: A Deep Dive into DMTsПодробнее

B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment LandscapeПодробнее